Results 111 to 120 of about 13,238 (216)
Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis
Introduction Different COVID-19 vaccines are being utilized as boosters. This systematic review and meta-analysis aims to evaluate the reactogenicity of COVID-19 vaccines given as booster doses, according to vaccine type, dose, timing, participant ...
Alberto San Francisco Ramos +11 more
doaj +1 more source
COVID-19 Vaccine Reactogenicity Among Young Children
This cross-sectional study examines reactogenicity among children of participants in the Centers for Disease Control and Prevention COVID-19 Vaccine Pregnancy Registry from November 2022 to September 2023 to understand the frequency and types of reactions experienced.
Madni, Sabrina A. +5 more
openaire +2 more sources
IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.
Thiago Dominguez Crespo Hirata (14435474) +17 more
core +1 more source
Physician Examination Reactogenicity in the 7 Days Following Dose 1 and Dose 2 of Vaccine Pooled Data.
Colin Gelder (3599288) +8 more
core +1 more source
The safety of influenza vaccine in clinically cured leprosy patients in China
Background: Leprosy is an infectious disease caused by the bacterium Mycobacterium leprae. Influenza vaccine is an important influenza prevention strategy and the preparations used display good safety and tolerability profiles. But the safety of applying
Yi Zheng +6 more
doaj +1 more source
Background: While mRNA vaccines effectively limit hospitalization and severe COVID-19 disease, the precise early innate immune mechanisms associated with their efficacy and reactogenicity remain underexplored.
Amanda E. Zelkoski +10 more
doaj +1 more source
Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley +1 more source
Dissecting lipid nanoparticle adjuvanticity and reactogenicity to optimize vaccine formulations
Hirai T., Yoshioka Y.. Dissecting lipid nanoparticle adjuvanticity and reactogenicity to optimize vaccine formulations. Current Opinion in Virology 76, 101540 (2026); https://doi.org/10.1016/j.coviro.2026.101540.mRNA vaccines have been proven to be ...
Yoshioka, Yasuo, Hirai, Toshiro
core +1 more source
Maximum systemic reactogenicity, prime vs boost, by treatment group.
Bar graphs show the percentage of participants in each treatment group reporting the specified maximum severity during the reactogenicity period. Left panels (Prime) indicate the maximum severity over all 3 priming injections.
Magdalena E. Sobieszczyk (332353) +18 more
core +1 more source
Local reactogenicity following rAd5 vaccine.
All subjects who received rAd5 vaccination by needle injection (n = 15) or by Biojector injection (n = 16) were counted once at worst severity over 5 days for solicited local parameters.
Julie E. Ledgerwood (253787) +11 more
core +1 more source

